β-Amyloid-induced neurodegeneration and protection by structurally diverse microtubule-stabilizing agents

Journal of Pharmacology and Experimental Therapeutics

Volumn 312, Issue 2, 2005, Pages 659-668

  Michaelis, M L ^a   Ansar, S ^a   Chen, Y ^a   Reiff, E R ^a   Seyb, K I ^a   Himes, R H ^a   Audus, K L ^a   Georg, G I ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

10 DEACETYLBACCATIN III; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[25-35]; BORNEOL; DISCODERMOLIDE; DOCETAXEL; EPOTHILONE A; PACLITAXEL; STABILIZING AGENT; TAXANE DERIVATIVE; TX 67; UK 100; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CELL; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; FETUS; MICROTUBULE; NERVE CELL CULTURE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KINETICS; MICROTUBULES; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; PACLITAXEL; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 13244295499     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.074450     Document Type: Article

References (40)

1. Arispe N, Rojas E, and Pollard HB (1993) Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc Natl Acad Sci USA 90:567-571.
2. Blagosklonny MV, Giannakakou P, el-Deiry WS, Kingston DG, Higgs PI, Neckers L, and Fojo T (1997) Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res 57:130-135.
3. Bollag DM, McQueney PA, Zhu J, Hensens O, Koupal L, Liesch J, Goetz M, Lazarides E, and Woods CM (1995) Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res 55:2325-2333.
4. Burke WJ, Raghu G, and Strong R (1994) Taxol protects against calcium-mediated death of differentiated rat pheochromocytoma cells. Life Sci 55:313-319.
5. Busciglio J, Lorenzo A, Yeh J, and Yankner BA (1995) beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14:879-888.
6. Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, and Bertino JR (1989) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86:695-698.
7. Cotman CW, Hailer NP, Pfister KK, Soltesz I, and Schachner M (1998) Cell adhesion molecules in neural plasticity and pathology: similar mechanisms, distinct organizations? Prog Neurobiol 55:659-669.
8. Dhavan R and Tsai LH (2001) A decade of CDK5. Nat Rev Mol Cell Biol 2:749-759.
9. Ferreira A, Lu Q, Orecchio L, and Kosik KS (1997) Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar A beta. Mol Cell Neurosci 9:220-234.
10. Figueroa-Masot XA, Hetman M, Higgins MJ, Kokot N, and Xia Z (2001) Taxol induces apoptosis in cortical neurons by a mechanism independent of Bcl-2 phosphorylation. J Neurosci 21:4657-4667.
11. Frame S and Cohen P (2001) GSK3 takes centre stage more than 20 years after its discovery. Biochem J 359:1-16.
12. Furukawa K and Mattson MP (1995) Taxol stabilizes [Ca2+]i and protects hippocampal neurons against excitotoxicity. Brain Res 689:141-146.
13. Furukawa K, Wang Y, Yao PJ, Fu W, Mattson MP, Itoyama Y, Onodera H, D'Souza I, Poorkaj PH, Bird TD, et al. (2003) Alteration in calcium channel properties is responsible for the neurotoxic action of a familial frontotemporal dementia tau mutation. J Neurochem 87:427-436.
14. Geula C, Wu CK, Saroff D, Lorenzo A, Yuan M, and Yankner BA (1998) Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat Med 4:827-831.
15. Gotz J (2001) Tau and transgenic animal models. Brain Res Brain Res Rev 35:266-286.
16. Grace EA, Rabiner CA, and Busciglio J (2002) Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Aizheimer's disease. Neuroscience 114:265-273.
17. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, and Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83:4913-4917.
18. Gundersen GG and Cook TA (1999) Microtubules and signal transduction. Curr Opin Cell Biol 11:81-94.
19. Ivins KJ, Thornton PL, Rohn TT, and Cotman CW (1999) Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8. Neurobiol Dis 6:440-449.
20. Klar U, Graf H, Schenk O, Röhr B, and Schulz H (1998) New synthetic inhibitors of microtubule depolymerization. Bioorg Med Chem Lett 8:1397-1402.
21. Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, and Wisniewski HM (1995) Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol (Berl) 89:35-41.
22. Lee VM (1995) Disruption of the cytoskeleton in Alzheimer's disease. Curr Opin Neurobiol 5:663-668.
23. Lee VM, Daughenbaugh R, and Trojanowski JQ (1994) Microtubule stabilizing drugs for the treatment of Alzheimer's disease. Neurobiol Aging 15:S87-S89.
24. Lee VM, Goedert M, and Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121-1169.
25. Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, et al. (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science (Wash DC) 293:1487-1491.
26. Li BS, Zhang L, Gu J, Amin ND, and Pant HC (2000) Integrin alpha(1) beta(1)-mediated activation of cyclin-dependent kinase 5 activity is involved in neurite outgrowth and human neurofilament protein H Lys-Ser-Pro tail domain phosphorylation. J Neurosci 20:6055-6062.
27. Li G, Faibushevich A, Turunen BJ, Yoon SO, Georg G, Michaelis ML, and Dobrowsky RT (2003) Stabilization of the cyclin-dependent kinase 5 activator, p35, by paclitaxel decreases beta-amyloid toxicity in cortical neurons. J Neurochem 84:347-362.
28. Lin MC and Kagan BL (2002) Electrophysiologic properties of channels induced by Abeta25-35 in planar lipid bilayers. Peptides 23:1215-1228.
29. Liu Y, Ali SM, Boge TC, Georg GI, Victory S, Zygmunt J, Marquez RT, and Himes RH (2002) A systematic SAR study of C10 modified paclitaxel analogues using a combinatorial approach. Comb Chem High Throughput Screen 5:39-48.
30. Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, and Cotman CW (1993) Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 90:7951-7955.
31. Mattson MP (1997) Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 77:1081-1132.
32. Michaelis ML, Ranciat N, Chen Y, Bechtel M, Ragan R, Hepperle M, Liu Y, and Georg G (1998) Protection against beta-amyloid toxicity in primary neurons by paclitaxel (Taxol). J Neurochem 70:1623-1627.
33. Michaelis ML, Walsh JL, Pal H, Hurlbert M, Hoel G, Bland K, Foye J, and Kwong WH (1994) Immunologic localization and kinetic characterization of a Na+/Ca2+ exchanger in neuronal and non-neuronal cells. Brain Res 661:104-116.
34. Pike CJ, Cummings BJ, and Cotman CW (1992) beta-Amyloid induces neuritic dystrophy m vitro: similarities with Alzheimer pathology. Neuroreport 3:769-772.
35. Rapoport M, Dawson HN, Binder LI, Vitek MP, and Ferreira A (2002) Tau is essential to beta-amyloid-induced neurotoxicity. Proc Natl Acad Sci USA 99:6364-6369.
36. Selkoe DJ (2001) Alzheimer's disease: genes, proteins and therapy. Physiol Rev 81:741-766.
37. Sigurdsson EM, Lee JM, Dong XW, Hejna MJ, and Lorens SA (1997) Bilateral injections of amyloid-beta 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical and time dependent histopathological effects. Neurobiol Aging 18:591-608.
38. Sponne I, Fifre A, Drouet B, Klein C, Koziel V, Pincon-Raymond M, Olivier JL, Chambaz J, and Pillot T (2003) Apoptotic neuronal cell death induced by the non-fibrillar amyloid-beta peptide proceeds through an early reactive oxygen species-dependent cytoskeleton perturbation. J Biol Chem 278:3437-3445.
39. Trushina E, Heldebrant MP, Perez-Terzic CM, Bortolon R, Kovtun IV, Badger JD 2nd, Terzic A, Estevez A, Windebank AJ, Dyer EB, et al. (2003) Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease. Proc Natl Acad Sci USA 100:12171-12176.
40. Yankner BA, Duffy LK, and Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science (Wash DC) 250:279-282.